Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-06

Clinical Trial Update: A Study to Test the Use of Duloxetine for Pain in MS [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/phase 3 clinical trial evaluating duloxetine for pain in people with multiple sclerosis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cymbalta (duloxetine)

Snippet

Sponsor: Brown, Theodore R., M.D., MPH | Conditions: Multiple Sclerosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-04-06